Overview ( Several members taking Afrezza )
This product is a rapid-acting inhaled insulin to improve glucose control in adults with diabetes mellitus. It is administered at the beginning of each meal.
This product has a Boxed Warning warning that acute bronchospasm (sudden narrowing of the lung passageways) has been observed in patients with asthma and chronic obstructive pulmonary disease (COPD). This product should not be used in patients with chronic lung disease, such as asthma or COPD because of this risk.
What is your Risk Rating for this medicine?
The risk of serious side effects for taking this medicine can be different if you take other medicines or if you suffer from a condition. Get your Risk Rating by creating a profile in a few steps.
- We monitor your health and alert you to any safety updates and recalls.
- You get to talk directly to other members about their experience.
- You can create profiles for you and your loved ones.
We check for possible drug-drug or drug-condition interactions for your medical treatment so you know when there is an issue. Drug interactions may create serious side effects that you want to discuss with your doctor.Register to check interactions